Massachusetts Financial Services Co. MA trimmed its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 9.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 217,021 shares of the technology company's stock after selling 23,171 shares during the quarter. Massachusetts Financial Services Co. MA owned about 0.81% of Plexus worth $31,902,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Salomon & Ludwin LLC acquired a new stake in Plexus in the third quarter worth $30,000. Allworth Financial LP grew its holdings in Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company's stock worth $36,000 after purchasing an additional 103 shares during the period. Johnson Financial Group Inc. acquired a new stake in Plexus in the third quarter worth $72,000. EverSource Wealth Advisors LLC grew its holdings in Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company's stock worth $78,000 after purchasing an additional 490 shares during the period. Finally, Smartleaf Asset Management LLC grew its holdings in Plexus by 33.0% in the third quarter. Smartleaf Asset Management LLC now owns 806 shares of the technology company's stock worth $115,000 after purchasing an additional 200 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Plexus
In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the firm's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total value of $1,921,557.40. Following the transaction, the chief operating officer directly owned 12,809 shares of the company's stock, valued at approximately $2,579,732.60. This trade represents a 42.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the firm's stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $203.06, for a total transaction of $873,767.18. Following the completion of the transaction, the chief accounting officer directly owned 20,099 shares in the company, valued at $4,081,302.94. This trade represents a 17.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 49,495 shares of company stock valued at $10,009,836. Corporate insiders own 1.78% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have commented on PLXS. Wall Street Zen cut shares of Plexus from a "buy" rating to a "hold" rating in a report on Sunday, March 8th. Williams Trading set a $195.00 price target on shares of Plexus in a report on Wednesday, January 28th. Needham & Company LLC raised their price target on shares of Plexus from $165.00 to $206.00 and gave the stock a "buy" rating in a report on Friday, January 30th. Benchmark restated a "buy" rating and issued a $220.00 price target on shares of Plexus in a report on Monday, March 16th. Finally, Stifel Nicolaus raised their price target on shares of Plexus from $150.00 to $200.00 and gave the stock a "hold" rating in a report on Friday, January 30th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $194.20.
Get Our Latest Analysis on PLXS
Plexus Stock Down 3.3%
Plexus stock opened at $220.49 on Thursday. Plexus Corp. has a 1-year low of $115.35 and a 1-year high of $232.17. The firm has a market capitalization of $5.91 billion, a price-to-earnings ratio of 34.29 and a beta of 0.75. The firm's fifty day moving average price is $202.69 and its two-hundred day moving average price is $171.17. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating analysts' consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same period last year, the firm earned $1.73 earnings per share. The business's quarterly revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.
Plexus Company Profile
(
Free Report)
Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.